Innovacell - Biotechnologie



Innovacell's business activities and its clinical development programme have been financed by the following, closely engaged investors:


Buschier AG

      Management team

FIDES Beteiligungs GmbH

      Private Investors

Hypo EQUITY Beteiligungs AG


P.S.K. Beteiligungsverwaltungs GmbH





Innovacell is an enterprise supported by equity capital. The potential of the innovative cell therapy, the results so far achieved and the development steps to come have convinced venture capital and other investors over the long term and underlined the quality of the performance.